Mediclinic International P/E 2024

Mediclinic International Aktienanalyse

What does Mediclinic International do?

Mediclinic International PLC is a leading global healthcare provider that treats patients in a variety of medical specialties. The company was founded in South Africa in 1983 and has since grown steadily. Today, it is represented in various countries such as South Africa, the United Kingdom, and the United Arab Emirates. Mediclinic's business model is based on providing its patients with high-quality medical care. The company operates various clinics and facilities that are specifically tailored to the needs of patients. These include general clinics, specialty clinics, and clinics specialized in treating certain diseases or patient groups. Under the Mediclinic International PLC umbrella, there are various divisions that cover different medical services. One important division is Mediclinic Southern Africa, which focuses on providing healthcare services in South Africa. In this segment, the company operates several hospitals, clinics, and medical facilities that all operate at a high level. Another important division is Mediclinic Middle East, which focuses on caring for patients in the United Arab Emirates. The company operates several clinics that specialize in various medical specialties. These include clinics for pediatrics, orthopedics, and neurology, as well as clinics specializing in the treatment of cancer and other serious illnesses. A third important division of Mediclinic is Mediclinic Switzerland, which operates various clinics and medical facilities in Switzerland. Here, the company focuses primarily on providing high-quality medical services in areas such as orthopedics and oncology. In addition to the various divisions, Mediclinic also operates a range of products targeting patients and medical professionals. These include various medical devices used in the diagnosis and treatment of patients. Furthermore, the company also offers a range of medical training and continuing education programs to support and keep medical professionals up to date. Overall, Mediclinic International PLC aims to provide patients in different countries and medical specialties with the best possible care. The company operates a variety of clinics and facilities, each operating at a high level. Additionally, Mediclinic offers a range of products and medical training to support both patients and professionals. Mediclinic International ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering Mediclinic International's P/E Ratio

The Price to Earnings (P/E) Ratio of Mediclinic International is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Mediclinic International's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Mediclinic International is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Mediclinic International’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Mediclinic International Stock

What is the price-to-earnings ratio of Mediclinic International?

The price-earnings ratio of Mediclinic International is currently 15.93.

How has the price-earnings ratio of Mediclinic International changed compared to last year?

The price-to-earnings ratio of Mediclinic International has increased by 0% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Mediclinic International high compared to other companies?

Yes, the price-to-earnings ratio of Mediclinic International is high compared to other companies.

How does an increase in the price-earnings ratio of Mediclinic International affect the company?

An increase in the price-earnings ratio of Mediclinic International would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Mediclinic International affect the company?

A decrease in the price-earnings ratio of Mediclinic International would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Mediclinic International?

Some factors that influence the price-earnings ratio of Mediclinic International are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Mediclinic International pay?

Over the past 12 months, Mediclinic International paid a dividend of 0.03 GBP . This corresponds to a dividend yield of about 0.6 %. For the coming 12 months, Mediclinic International is expected to pay a dividend of 0.03 GBP.

What is the dividend yield of Mediclinic International?

The current dividend yield of Mediclinic International is 0.6 %.

When does Mediclinic International pay dividends?

Mediclinic International pays a quarterly dividend. This is distributed in the months of January, July, January, September.

How secure is the dividend of Mediclinic International?

Mediclinic International paid dividends every year for the past 6 years.

What is the dividend of Mediclinic International?

For the upcoming 12 months, dividends amounting to 0.03 GBP are expected. This corresponds to a dividend yield of 0.59 %.

In which sector is Mediclinic International located?

Mediclinic International is assigned to the 'Health' sector.

Wann musste ich die Aktien von Mediclinic International kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Mediclinic International from 8/26/2022 amounting to 0.03 GBP, you needed to have the stock in your portfolio before the ex-date on 8/4/2022.

When did Mediclinic International pay the last dividend?

The last dividend was paid out on 8/26/2022.

What was the dividend of Mediclinic International in the year 2023?

In the year 2023, Mediclinic International distributed 0.03 GBP as dividends.

In which currency does Mediclinic International pay out the dividend?

The dividends of Mediclinic International are distributed in GBP.